Frivelle 1,5 mg tabletter
Active ingredient: Levonorgestrel
View notice details →
News topic
All current shortage notices related to Expected end: Anfang November 2026, structured by product, country, active ingredient and reporting period.
10 noticesActive ingredient: Levonorgestrel
View notice details →Active ingredient: nicht angegeben
View notice details →Active ingredient: nicht angegeben
View notice details →Active ingredient: nicht angegeben
View notice details →Active ingredient: Kaliumchlorid, macrogol 3350, natriumchlorid og natriumhydrogencarbonat
View notice details →Active ingredient: Pneumokok polysaccharid serotype 1, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 2, 20, 22F, 23F, 3, 33F, 4, 5, 7F, 8, 9N og 9V
View notice details →Active ingredient: Latanoprost, timolol
View notice details →Active ingredient: Loratadin
View notice details →Active ingredient: Insulin aspart; insulin degludec
View notice details →Active ingredient: Mannitol
View notice details →For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.
Researching this shortage professionally? We assess sourcing routes, suppliers and cross-border supply against your requirements. A notice does not confirm stock availability.
Send a sourcing enquiry →Medicine storage, batch and expiry control, picking and distribution for Germany and Europe. We agree the storage profile, temperature and capacity with you.
Request warehouse capacity →